Related Experiment Video
Updated: Feb 3, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Diabetes Mellitus: Preoperative Concerns and Evaluation.
Roshni Sreedharan1, Basem Abdelmalak2
1Department of General Anesthesiology, Center for Critical Care, Anesthesiology Institute, Cleveland Clinic, E-31 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Managing diabetes perioperatively is crucial for preventing complications like blindness and cardiovascular events. This review offers guidance on preoperative diabetes management and pharmacotherapy, including insulin pumps, to optimize surgical outcomes.
Area of Science:
- Anesthesiology
- Endocrinology
- Metabolic Disorders
Background:
- Diabetes mellitus is a significant contributor to adult morbidity, leading to severe complications such as blindness, renal dysfunction, cardiovascular events, and limb amputation.
- These diabetes-related morbidities can substantially influence perioperative anesthetic care and patient outcomes.
- Effective management of patients with diabetes, and even those with hyperglycemia without a diabetes diagnosis, is critical in the perioperative setting.
Purpose of the Study:
- To review preoperative considerations for managing patients with diabetes and hyperglycemia.
- To propose a pharmacotherapy plan for preoperative diabetes management.
- To discuss criteria for proceeding with or canceling surgery based on glycemic control.
Main Methods:
- This study is a review of existing literature and clinical guidelines.
- It synthesizes information on preoperative assessment and management strategies for diabetic patients.
- The review includes recommendations for pharmacotherapy adjustments and glycemic targets.
Main Results:
- Preoperative hyperglycemia poses risks that necessitate careful management.
- A structured approach to diabetes pharmacotherapy, including the potential use of subcutaneous insulin pumps, can help prevent hypoglycemia and hyperglycemia.
- Establishing clear guidelines for surgical decisions based on hemoglobin A1c and blood glucose levels is essential.
Conclusions:
- Optimal perioperative anesthetic care for patients with diabetes requires proactive management of glycemic control.
- The proposed pharmacotherapy plan and surgical decision-making criteria aim to improve patient safety and outcomes.
- Addressing preoperative hyperglycemia is vital for reducing surgical risks and complications.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications

